|
Ensuring access to vaccines and related products =>> Development and introduction of new, near-term products =>>
Monitor the progress towards establishing the public health benefit and demand for rotavirus and pneumococcal vaccines in developing countries
Responsible entity: Secretariat
Completed by: December 2005
Total budget: $494,490
Total budget includes Secretariat's salaries: $364,490
Target description and how it will help reach GAVI milestones
One of GAVI’s strategic objectives is to accelerate the development and introduction of new vaccines and technologies into developing countries. After a thorough investigation, GAVI identified two priority vaccines, Streptococcus pneumonia and rotavirus, for its initial efforts. These diseases are responsible for the deaths of nearly 2 million children each year, and both have promising candidate vaccines in advanced stages of development. The ADIP's aim to shorten the lag between vaccines being proven safe and effective for use in the industrialized world and their introduction in developing countries. GAVI has awarded PATH and Johns Hopkins University's ADIP projects with 30 millions for each project. This task aims to ensure the GAVI Board monitoring of the ADIP's progress.
PNEUMO & ROTA MILESTONE: Monitoring of ADIP projects allows GAVI Board to direct and influence if necessary the progress towards reaching the milestone.
Justification for selection of activities
The ADIP Management Committee needs facilitation support from the GAVI Secretariat to monitor ADIP projects activities and to advise GAVI Board on go/no-go decisions.
Alignment of ADIP research focus with vaccine introduction efforts ensures better integration with other GAVI priorities.
ACTION PLAN
| Activities |
Budget |
Coordinating partner/ support partners |
Expected outcomes |
| GAVI ADIP Management Committee meetings and teleconferences |
$130,000 |
Secretariat ADIP MC |
• The review of ADIP progress, future plans and budgets will be done at the Committee meetings (on a biennial basis); this will form the bases for GAVI Board endorsement for projects support. Interim teleconferences will provide additional forum for discussions. |
| Alligning of ADIP research focus with ongoing GAVI vaccine introduction efforts: ad-hoc meetings |
$0 |
Vaccine Fund VPP UNICEF FTF WHO |
• The ADIP projects and other GAVI ongoing activities are working in synergy towards the common objectives of improving access to life-saving vaccines. |
| Post-ADIP-s options and action plan |
$0 |
ADIP teams GAVI Board VF ADIP MC |
• GAVI Board and Vaccine Fund will be presented with draft investment cases by ADIP teams to initiate the discussion of rota and pneumococcal vaccine introduction support to VF eligible countries. Post ADIPs options will be discussed. |
|
|
|
|
Targets by priority area
Ensuring access to vaccines and related products
==>> Procurement/Supply of existing products
==>> Development and introduction of new, near-term products
• Technologies for immunization: prioritization reviews, evaluations and advocacy.
• Monitor the progress towards establishing the public health benefit and demand for rotavirus and pneumococcal vaccines in developing countries
==>> Managing process for country support from Vaccine Fund
Securing long-term financing
==>> Financial sutainability
==>> Recapitalization of The Vaccine Fund
Strategic planning & monitoring
==>> Setting priorities
==>> Monitoring progress
Other
==>> Alliance coordination
Strengthening service delivery
==>> Health information and monitoring systems
==>> Contributing to alleviation of system-wide barriers
==>> Enhanced efforts in large population countries |
|